Search

Guliang Xia

from San Diego, CA
Age ~56

Guliang Xia Phones & Addresses

  • 11217 Carmel Creek Rd UNIT 5, San Diego, CA 92130
  • 827 Lavergne Ave, Wilmette, IL 60091 (847) 251-1617
  • 7504 Center St, Milwaukee, WI 53210 (414) 259-1893
  • Wauwatosa, WI
  • 903 Clinton Ave, Oak Park, IL 60304 (708) 383-3832
  • 422 Forest St, Columbus, OH 43206 (614) 444-3835
  • Seattle, WA
  • 7504 W Center St, Milwaukee, WI 53210 (414) 534-4124

Work

Company: Novo nordisk research center china Apr 2014 Position: Manager and head of department

Education

School / High School: The Ohio State University- Columbus, OH 2000 Specialities: Post-Doctoral in Cell Biology

Languages

Chinese • English

Industries

Pharmaceuticals

Resumes

Resumes

Guliang Xia Photo 1

Manager, Drug Discovery Immunology (Rheumatology & Transplantation Immunology)

View page
Position:
Manager at Astellas Pharma Inc - ARIA
Location:
Skokie, Illinois
Industry:
Pharmaceuticals
Work:
Astellas Pharma Inc - ARIA - Skokie since Mar 2009
Manager

Northwestern University - Chicago Nov 2003 - Mar 2009
Assistant Professor (Research), Transplant Immunology

Medical College of Wisconsin - Milwaukee Dec 2001 - Oct 2003
Research Scientist

The Ohio State University - Columbus, Ohio Area Mar 2000 - Dec 2001
Post-doctoral researcher
Education:
University of Leuven, Belgium 1997 - 2000
PhD, Immunology and Transplantation
Tongji Medical College 1990 - 1993
Master's degree, Surgical Science / Transplantation
Tongji Medical College, China 1985 - 1990
Bachelor of Medicine, Medicine
Languages:
Chinese
English
Guliang Xia Photo 2

Guliang Xia Wilmette, IL

View page
Work:
Novo Nordisk Research Center China

Apr 2014 to Oct 2014
Manager and Head of Department

ASTELLAS RESEARCH INSTITUTE OF AMERICA
Skokie, IL
Apr 2011 to Aug 2013
Manager

NORTHWESTERN UNIVERSITY
Chicago, IL
Nov 2003 to Mar 2009
Assistant Professor (Research)

MEDICAL COLLEGE OF WISCONSIN
Milwaukee, WI
Dec 2001 to Oct 2003
Research Scientist

TONGJI HOSPITAL / TONGJI MEDICAL UNIVERSITY
Wuhan, CN
Jul 1993 to Mar 1997
Surgical Resident and Attending Surgeon

Education:
The Ohio State University
Columbus, OH
2000 to 2001
Post-Doctoral in Cell Biology

University of Leuven
2000
PhD in Biomedical Science

Tongji Medical University
Wuhan, CN
1993
MS in Immunology

Tongji Medical University
Wuhan, CN
1990
Medicine

Publications

Us Patents

Novel Compound, And Method For Producing Regulatory T Cells

View page
US Patent:
20190382403, Dec 19, 2019
Filed:
Jan 30, 2018
Appl. No.:
16/479229
Inventors:
- Kyoto, JP
- Tokyo, JP
Norihisa MIKAMI - Kyoto, JP
Shuh NARUMIYA - Kyoto, JP
Masahiko AKAMATSU - Tokyo, JP
Guliang XIA - San Diego CA, US
Hironori HARADA - Tokyo, JP
Naoto NAKAMURA - Tokyo, JP
Satoru UJIHARA - Tokyo, JP
Hisao HAMAGUCHI - Tokyo, JP
Assignee:
Kyoto University - Kyoto
Astellas Pharma Inc. - Tokyo
International Classification:
C07D 471/04
A61K 35/17
C12N 5/0783
A61P 37/08
A61P 29/00
A61P 37/06
Abstract:
Provided are a novel compound having CDK8 and/or CDK19 inhibitory activity, and a production method for Tregs. The treatment of T cells with a CDK8 and/or CDK19 inhibitor induces Foxp3 in the T cells. Foxp3T cells can be induced by treating Foxp3 T cells with the CDK8 and/or CDK19 inhibitor in vitro. Thus, Tregs can be induced.
Guliang Xia from San Diego, CA, age ~56 Get Report